(Q54265665)

English

Neuroblastoma

scientific article published in The Lancet

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

Europe PubMed Central

Neuroblastoma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

John M Maris

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Michael D Hogarty

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Rochelle Bagatell

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

0 references

publication date

1 June 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

369

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

2106-2120

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

9579

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroblastoma. Mass screening for early detection and its prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the mass screening of neuroblastoma in Sapporo City

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroblastoma Screening at One Year of Age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening of infants and mortality due to neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ocular involvement in neuroblastoma: prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pediatric horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A prospective study of 42 patients--results of the NBL 90 Study of the French Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroblastoma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antineuronal Antibodies in Patients With Neuroblastoma and Paraneoplastic Opsoclonus-Myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with intravenously administered immunoglobulins of the neuroblastoma-associated opsoclonus-myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Special pattern of widespread neuroblastoma with a favourable prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperdiploidy Plus NonamplifiedMYCNConfers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene amplification in human neuroblastomas: basic mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Detailed molecular analysis of 1p36 in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosome 1p and 11q deletions and outcome in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Variety and complexity of chromosome 17 translocations in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic Staging of Unresectable or Metastatic Neuroblastomain Infants: a Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroblastoma: biological insights into a clinical enigma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful management of low-stage neuroblastoma without adjuvant therapies: a comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroblastoma study NBL 79 of the German Society for Pediatric Oncology. Report after 2 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Spontaneous regression of localized neuroblastoma detected by mass screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatomegaly in neuroblastoma stage 4s: criteria for treatment of the vulnerable neonate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Metaiodobenzylguanidine assessment of metastatic neuroblastoma: observer dependency and chemosensitivity evaluation. The SFOP Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institut Gustave-Roussy in France

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular genetic analysis of familial neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Familial neuroblastoma. Case reports, literature review, and etiologic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondine's curse and neurocristopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Developmental Genetics of Neuroblastoma12

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroblastoma and ganglioneuroma in a child with multiple neurofibromatosis. Implications for the mutational origin of neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Synchronous neuroblastoma and von Recklinghausen's disease: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Familial neuroblastoma: a three-generation pedigree and a further association with Hirschsprung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Idiopathic congenital central hypoventilation syndrome: Analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Germline PHOX2B mutation in hereditary neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Trk receptor tyrosine kinases: a bridge between cancer and neural development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression and function of TRK-B and BDNF in human neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Signaling networks that link cell proliferation and cell fate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in PIK3CA are infrequent in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted expression of MYCN causes neuroblastoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The MYCN enigma: significance of MYCN expression in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Notch signaling in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The Hedgehog and Wnt signalling pathways in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Wnt signalling in stem cells and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of cerebral cortical size by control of cell cycle exit in neural precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome era.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of low level genomic alterations by comparative genomic hybridization based on cDNA micro-arrays.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-resolution detection and mapping of genomic DNA alterations in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A Phase I Study of Irinotecan As a 3-Week Schedule in Children With Refractory or Recurrent Solid Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Topotecan in the treatment of refractory neuroblastoma and other malignant tumors in childhood - a phase-II-study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

131I MIBG therapy in neuroblastoma: mechanisms, rationale, and current status

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted Radiotherapy With Submyeloablative Doses of 131I-MIBG Is Effective for Disease Palliation in Highly Refractory Neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced activity of hu14.18-IL2 immunocytokine against murine NXS2 neuroblastoma when combined with interleukin 2 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic engineering of cytolytic T lymphocytes for adoptive T-cell therapy of neuroblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Retinoid therapy of high-risk neuroblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Down-regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular endothelial growth factor expression in human neuroblastoma: up-regulation by hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

TNP-470 antiangiogenic therapy for advanced murine neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960983-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(07)60983-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17586306%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54265665&oldid=2133884175"